Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study

Yu Lei1, Junjun An, Qingchun Ren

  • 1Department of Otorhinolaryngology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.

Medicine
|October 31, 2023
PubMed

Insights

Membrane type 1-matrix metalloproteinases (MMP-14) are crucial in middle ear cholesteatoma development. Higher MMP-14 expression correlates with increased bone destruction, not age, gender, or hearing loss severity.

Area of Science:

  • Otolaryngology
  • Molecular Biology
  • Pathogenesis Research

Background:

  • Cholesteatoma is a destructive, noncancerous epithelial growth in the middle ear.
  • Understanding cholesteatoma's molecular pathogenesis is key to managing its destructive potential.
  • Membrane type 1-matrix metalloproteinases (MMP-14) are implicated in tissue remodeling and invasion.

Purpose of the Study:

  • To investigate the expression of MMP-14 in middle ear cholesteatoma.
  • To identify factors influencing MMP-14 expression in cholesteatoma.
  • To elucidate the role of MMP-14 in cholesteatoma pathogenesis at a molecular level.

Main Methods:

  • Prospective study analyzing 39 middle ear cholesteatoma specimens and 10 external auditory meatus epithelial samples.
  • Immunohistochemical staining used to assess MMP-14 expression.
  • Statistical analysis performed to correlate MMP-14 levels with clinical factors and bone destruction severity.

Main Results:

  • MMP-14 expression was significantly higher in middle ear cholesteatoma patients compared to normal controls (P < .05).
  • MMP-14 expression showed a positive correlation with the severity of ossicular bone destruction (R = 0.535, P < .05).
  • No statistically significant correlation was found between MMP-14 expression and patient gender, age, or degree of hearing loss (P > .05).

Conclusions:

  • MMP-14 plays a significant role in the pathological development of cholesteatoma epithelium.
  • MMP-14 expression is a potential biomarker for the destructive capacity of middle ear cholesteatoma.
  • Targeting MMP-14 may offer therapeutic strategies for cholesteatoma, particularly in cases with significant bone erosion.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
The Extracellular Matrix01:29

The Extracellular Matrix

Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
9.0K